Clinical Trials
- This forum has 759 topics, 1,631 replies, and was last updated 2 years, 3 months ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- First-in-human (FIH) phase I study of GST-HG161, a potent and highly selective c
- 1
- 1
- 4 years, 6 months ago
- Safety and feasibility of systemic anticancer therapy in gastrointestinal (GI) c
- 1
- 1
- 4 years, 6 months ago
- Phase I study of rucaparib and irinotecan in advanced solid tumors with homologo
- 1
- 1
- 4 years, 6 months ago
- Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every t
- 1
- 1
- 4 years, 6 months ago
- Pilot study on outcome and antitumor efficacy of an autologous cancer cell vacci
- 1
- 1
- 4 years, 6 months ago
- Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid
- 1
- 1
- 4 years, 6 months ago
- Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb;
- 1
- 1
- 4 years, 6 months ago
- A phase II study of selective HDAC6 inhibition with KA2507 for second-line treat
- 1
- 1
- 4 years, 6 months ago
- Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liv
- 1
- 1
- 4 years, 6 months ago
- IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association
- 1
- 1
- 4 years, 6 months ago
- Phase II basket trial of olaparib and durvalumab in patients (pts) with isocitra
- 1
- 1
- 4 years, 6 months ago
- Final results from the phase I study expansion cohort of the selective FGFR inhi
- 1
- 1
- 4 years, 6 months ago
- FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patient
- 1
- 1
- 4 years, 6 months ago
- The forum ‘Clinical Trials’ is closed to new topics and replies.